Table 3 Clinical characteristics versus outcomes
Variable | n (%) | Amputation | Debridement | §Disarticulation | P-value |
|---|---|---|---|---|---|
n (%) | n (%) | n (%) | |||
DM type | |||||
Type I | 1 (1.67) | 0 (0.00) | 1 (100.00) | 0 (0.00) | 0.483 |
Type II | 59 (98.33) | 31 (52.54) | 20 (33.90) | 8 (13.56) | |
Duration of DM in years | |||||
< 1 | 5 (8.33) | 1 (20.00) | 2 (40.00) | 2 (40.00) | 0.118 |
1–5 | 21 (35.00) | 12 (57.14) | 5 (23.81) | 4 (19.05) | |
> 5 | 34 (56.67) | 18 (52.94) | 14 (41.18) | 2 (5.88) | |
Antidiabetic agent | |||||
Injection | 23 (38.33) | 11 (47.83) | 10 (43.48) | 2 (8.70) | 0.66 |
Oral | 32 (53.33) | 18 (56.25) | 9 (28.13) | 5 (15.63) | |
Herbal | 5 (8.33) | 2 (40.00) | 2 (40.00) | 1 (20.00) | |
Prior history of amputation | |||||
No | 57 (95.00) | 30 (52.63) | 19 (33.33) | 8 (14.04) | 0.715 |
Yes | 3 (5.00) | 1 (33.33) | 2 (66.67) | 0 (0.00) | |
Meggitt-Wagner classification | |||||
1 | 2 (3.33) | 0 (0.00) | 2 (100.00) | 0 (0.00) | < 0.001 |
2 | 16 (26.67) | 0 (0.00) | 10 (62.50) | 6 (37.50) | |
3 | 28 (46.67) | 17 (60.71) | 9 (32.14) | 2 (7.14) | |
4 | 13 (21.67) | 13 (100.00) | 0 (0.00) | 0 (0.00) | |
5 | 1 (1.67) | 1 (100.00) | 0 (0.00) | 0 (0.00) | |
Haemoglobin (g/dl) | |||||
< 7 | 8 (13.33) | 4 (50.00) | 3 (37.50) | 1 (12.50) | 0.525 |
07–10 | 23 (38.33) | 15 (65.22) | 7 (30.43) | 1 (4.35) | |
> 10–12 | 11 (18.33) | 4 (36.36) | 4 (36.36) | 3 (27.27) | |
> 12 | 18 (30.00) | 8 (44.44) | 7 (38.89) | 3 (16.67) | |
RBG (mmol/l)) | |||||
< 10 | 18 (30.00) | 8 (44.44) | 7 (38.89) | 3 (16.67) | 0.94 |
10–19 | 28 (46.67) | 15 (53.57) | 9 (32.14) | 4 (14.29) | |
≥ 20 | 14 (23.33) | 8 (57.14) | 5 (35.71) | 1 (7.14) | |
Hypertensive | |||||
No | 34 (56.67) | 18 (52.94) | 11 (32.35) | 5 (14.71) | 0.877 |
Yes | 26 (43.33) | 13 (50.00) | 10 (38.46) | 3 (11.54) | |
duration of ulcers (months) | |||||
< 1 | 40 (66.67) | 22 (55.00) | 13 (32.50) | 5 (12.50) | 0.744 |
≥ 1 | 20 (33.33) | 9 (45.00) | 8 (40.00) | 3 (15.00) | |
Total | 60 (100.0) | 31 (51.67) | 21 (35.00) | 8 (13.33) | |